![Hermes Garbán](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Hermes D.
Garbán worked as a Professor at the University of California, Los Angeles from 2005 to 2014.
He was also a Principal Investigator at The California NanoSystems Institute.
From 2014 to 2019, he worked at Nantbio, Inc. as the Head of Therapeutics Discovery & Development.
In 2017, he became the Deputy VP-Global Cell Manufacturing at NantKwest, Inc. He also worked as the Head of Therapeutics Discovery & Development at NantCell, Inc. In 2019, he joined ImmunityBio, Inc. as the Head of Therapeutics Discovery & Development until 2021.
In 2021, he became the Chief Medical Officer at Vincerx Pharma, Inc. Dr. Garbán holds a doctorate degree from the University of California, Los Angeles, Central University of Venezuela, and the University of California.
Anciens postes connus de Hermes Garbán
| Sociétés | Poste | Fin |
|---|---|---|
| VINCERX PHARMA, INC. | Directeur Technique/Scientifique/R&D | 01/08/2022 |
| IMMUNITYBIO, INC. | Corporate Officer/Principal | 01/02/2021 |
Nantbio, Inc.
 Nantbio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops molecular drugs | Corporate Officer/Principal | 01/03/2019 |
| IMMUNITYBIO, INC. | Corporate Officer/Principal | 01/10/2018 |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2014 |
Formation de Hermes Garbán
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
94
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
NantKwest, Inc.
 NantKwest, Inc. BiotechnologyHealth Technology Develops and produces cancer treatment products | Health Technology |
Nantbio, Inc.
Nantbio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops molecular drugs | Health Technology |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Central University of Venezuela
 Central University of Venezuela Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California
 University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The California NanoSystems Institute
 The California NanoSystems Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NantCell, Inc.
 NantCell, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for immunogenic diseases | Health Technology |
Vincerx Pharma, Inc.
 Vincerx Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies to address cancer | Health Technology |
ImmunityBio, Inc.
 ImmunityBio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for immunogenic mechanisms for defeating cancer and infectious disease | Health Technology |
Choisissez Zonebourse 
